New startup to focus on psychedelics ’ potential to treat addiction, depression

The company is looking to create synthetic versions of LSD and psilocybin mushrooms, without the hallucinogenic effects.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 21, 2020 Category: Pharmaceuticals Authors: Felicia Alvarez Source Type: news